Divi's Laboratories (NSE:DIVISLAB) Construction In Progress: ₹21,130 Mil (As of Mar. 2026)


NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
93 GF Score
Price ₹6,753.50
GF Value ₹6,729.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Divi's Laboratories Construction In Progress?

Divi's Laboratories NSE:DIVISLAB +0.10% 93 Construction In Progress is ₹21,130 Mil as of Mar. 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 93/100 and a GF Value™ of ₹6,729.63 (Fairly Valued). The stock has 5 warning signs investors should review.

Divi's Laboratories's quarterly construction in progress declined from Sep. 2025 (₹20,300 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹21,130 Mil).

Divi's Laboratories's annual construction in progress increased from Mar. 2024 (₹8,970 Mil) to Mar. 2025 (₹12,600 Mil) and increased from Mar. 2025 (₹12,600 Mil) to Mar. 2026 (₹21,130 Mil).

Divi's Laboratories Construction In Progress Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Construction In Progress Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,182.50 2,310.00 8,970.00 12,600.00 21,130.00

Divi's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,600.00 0.00 20,300.00 0.00 21,130.00
NSE:DIVISLAB
93GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹21,130 Mil mean?
Divi's Laboratories (NSE:DIVISLAB) has a Construction In Progress of ₹21,130 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Divi's Laboratories and its competitors.
Is Divi's Laboratories' Construction In Progress too high?
Divi's Laboratories' current Construction In Progress is ₹21,130 Mil. Overall, Divi's Laboratories has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Construction In Progress compare to ZTS?
Divi's Laboratories' Construction In Progress of ₹21,130 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Divi's Laboratories and its competitors. Divi's Laboratories's current Construction In Progress is ₹21,130 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,729.63, compared to a current price of ₹6,753.50 — trading 0.4% above its estimated fair value. The current Construction In Progress is ₹21,130 Mil. Divi's Laboratories' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Construction In Progress is ₹21,130 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹6,753.50 is trading 0.4% above its estimated GF Value™ of ₹6,729.63. GuruFocus considers Divi's Laboratories to be Fairly Valued.

Key valuation signals for NSE:DIVISLAB:

  • Construction In Progress: ₹21,130 Mil
  • GF Value™: ₹6,729.63 vs. price of ₹6,753.50 (0.4% above fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
93GF Score

Get the complete analysis for NSE:DIVISLAB

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,753.50
Price
₹6,729.63
GF Value